Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Wolan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Biochemistry|October 11, 2022
The importance of verifying manufacturer's claim on specimen stability: An example in serum angiotensin converting enzyme testingVanessa Wolan, Andrea Kunst, Christina Gauvreau, et al.
International Journal of Neonatal Screening|October 19, 2020
Newborn Screening: Current Status in Alberta, CanadaAndy De Souza, Vanessa Wolan, Angie Battochio, et al.
International Journal of Neonatal Screening|November 29, 2021
The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular TestingJanet R Zhou, Ross Ridsdale, Lauren MacNeil, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Biochemistry|October 11, 2022
The importance of verifying manufacturer's claim on specimen stability: An example in serum angiotensin converting enzyme testingVanessa Wolan, Andrea Kunst, Christina Gauvreau, et al.
International Journal of Neonatal Screening|October 19, 2020
Newborn Screening: Current Status in Alberta, CanadaAndy De Souza, Vanessa Wolan, Angie Battochio, et al.
International Journal of Neonatal Screening|November 29, 2021
The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular TestingJanet R Zhou, Ross Ridsdale, Lauren MacNeil, et al.
Pageof 1